The assessment of quality of life as a primary outcome in cancer clinical trials is now almost universal. Such data are necessarily longitudinal and multidimensional, and are often severely unbalanced by missing values or early patient death. However, to date, their reporting in the applied literature has generally used simple descriptive summaries that ignore many of these complexities. Not only can these be misleading, but they generally do not allow firm conclusions to be drawn about a major endpoint. The aim of this thesis is to assess the practical application of recent developments in statistical methodology for the analysis of quality of life data collected using...
One way of examining trade-offs between quantity and quality of life (QOL) is to combine them into a...
Quality of Life (QL) is now included as an endpoint in many phase III cancer clinical trials. Numero...
International audienceBackground: Health-Related Quality of Life (HRQoL) is an important endpoint in...
The assessment of quality of life as a primary outcome in cancer clinical trials is now al...
The assessment of quality of life as a primary outcome in cancer clinical trials is now almost unive...
Background Health-related quality of life is a topic of current interest. This paper...
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials...
Classical end-points in clinical therapeutic trials in oncology are usually defined by total, recurr...
The aim of the thesis is to critically review, apply and where appropriate develop statistical metho...
The measurement of patient-reported outcomes, including health-related quality of life, is a new ini...
Quality of life (QoL) was an important endpoint in the adjuvant breast cancer trials International B...
Abstract Background The use of health-related quality of life (HRQoL) as an endpoint in cancer clini...
Background: There is currently a lack of consensus on how health-related quality of life and other p...
The health-related quality of life is a major objective in oncology clinical trials to improve patie...
BACKGROUND Information about the impact of cancer treatments on patients' quality of life (QoL) is o...
One way of examining trade-offs between quantity and quality of life (QOL) is to combine them into a...
Quality of Life (QL) is now included as an endpoint in many phase III cancer clinical trials. Numero...
International audienceBackground: Health-Related Quality of Life (HRQoL) is an important endpoint in...
The assessment of quality of life as a primary outcome in cancer clinical trials is now al...
The assessment of quality of life as a primary outcome in cancer clinical trials is now almost unive...
Background Health-related quality of life is a topic of current interest. This paper...
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials...
Classical end-points in clinical therapeutic trials in oncology are usually defined by total, recurr...
The aim of the thesis is to critically review, apply and where appropriate develop statistical metho...
The measurement of patient-reported outcomes, including health-related quality of life, is a new ini...
Quality of life (QoL) was an important endpoint in the adjuvant breast cancer trials International B...
Abstract Background The use of health-related quality of life (HRQoL) as an endpoint in cancer clini...
Background: There is currently a lack of consensus on how health-related quality of life and other p...
The health-related quality of life is a major objective in oncology clinical trials to improve patie...
BACKGROUND Information about the impact of cancer treatments on patients' quality of life (QoL) is o...
One way of examining trade-offs between quantity and quality of life (QOL) is to combine them into a...
Quality of Life (QL) is now included as an endpoint in many phase III cancer clinical trials. Numero...
International audienceBackground: Health-Related Quality of Life (HRQoL) is an important endpoint in...